Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) or COVID-19 Pandemic Resuscitation Plans and Decisions on Escalation and Limitation of Treatment

NCT04743232 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT04743232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04743232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) or COVID-19 Pandemic Resuscitation Plans and Decisions on Escalation and Limitation of Treatment
Lead sponsor
Erasmus Medical Center
Phase
Not applicable
Overall status
Suspended
Start date
March 1, 2021
Completion date
January 31, 2025
Enrollment
200 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrest, covid19